SEARCH

SEARCH BY CITATION

References

  • 1
    Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125138.
  • 2
    Strehlau J. Cytotoxic T lymphocyte monitoring in steroid-free immunosuppression. Pediatr Transplant 2003; 7: 46.
  • 3
    Strehlau J, Pavlakis M, Lipman M, Shapiro M, Strom TB. Quantitative detection of immune activation genes as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci 1997; 94: 695700.
  • 4
    Meier-Kriesche HU, Ojo AO, Hanson JA et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000; 70: 10981100.
  • 5
    Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603612.
  • 6
    Hippen BE, DeMattos A, Cook WJ, Kew CE 2nd, Gaston RS. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005; 5: 22482252.
  • 7
    Maloney DG, Grillo-Lopez AJ, White CA et al. IDECC2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed lowgrade non-Hodgkin's lymphoma. Blood 1997; 90: 21882195.
  • 8
    Mounier N, Briere J, Gisselbrecht C et al. Rituximab plus CHOP (R-CHOP) overcomes bcl-2–associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood 2003; 101: 42794284. Epub 2003 Feb 4276.
  • 9
    Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005; 23: 2368.
  • 10
    Rivera A, Chen CC, Ron N, Dougherty JP, Ron Y. Role of B cells as antigen-presenting cells in vivo revisited: Antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol 2001; 13: 15831593.
  • 11
    Demirci G, Amanullah F, Kewalaramani R et al. Critical role of OX40 in CD28 and CD154-independent rejection. J Immunol 2004; 172: 16911698.
  • 12
    Baan CC, Van Der Mast BJ, Klepper M et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 2005; 80: 110117.
  • 13
    Schachter AD, Strehlau J, Zurakowski D et al. Increased nuclear factor-kappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis. Transplantation 2000; 70: 11071110.